NCT02808312View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

July 13, 2016

Primary Completion Date

October 16, 2018

Study Completion Date

October 16, 2018

Conditions
Nonalcoholic Steatohepatitis (NASH)Primary Sclerosing Cholangitis (PSC)
Interventions
DRUG

Cilofexor

Tablet(s) administered orally in a fed state on Day 1

Trial Locations (5)

1640

Auckland

32809

Orlando

33014

Miami

37920

Knoxville

78215

San Antonio

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY